Takeda Pharmaceutical Non-GAAP EPS of ¥456.00, revenue of ¥3071.3B; reaffirms full-year gu

, ,

Takeda Pharmaceutical press release (NYSE:TAK): 9M Non-GAAP EPS of ¥456.00.
Revenue of ¥3071.3B (+19.8% Y/Y).
FY Guidance: Revenue guidance unchanged to ¥3.93T. Core EPS of ¥525; Core Operating Profit of ¥1,180.0B and Free Cash Flow of ¥650.0B - ¥750.0B.

More Trending News

Symbol	Last Price	% Chg
TKPHF TKPHF	-	-
TAK TAK	-	-

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.